Home
Market Capitalization of Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Ltd
NSE: OXYGENTAPHARMA
Market Cap
Key Highlights
- The Market Cap of Oxygenta Pharmaceutical Ltd is ₹ 286.36 crore as of 13 Mar 25 .
- The Latest Trading Price of Oxygenta Pharmaceutical Ltd is ₹ 77.43 as of 13 Mar 15:30 .

Oxygenta Pharmaceutical Ltd
NSE: OXYGENTAPHARMA
Share Price
Market Price of Oxygenta Pharmaceutical Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
13 Mar 2025 | 77.43 |
12 Mar 2025 | 79.01 |
11 Mar 2025 | 79.4 |
10 Mar 2025 | 77.87 |
07 Mar 2025 | 76.35 |
06 Mar 2025 | 74.86 |
05 Mar 2025 | 73.4 |
04 Mar 2025 | 71.97 |
03 Mar 2025 | 73.43 |
28 Feb 2025 | 74.92 |
SWOT Analysis Of Oxygenta Pharmaceutical Ltd
BlinkX Score for Oxygenta Pharmaceutical Ltd
Asset Value vs Market Value of Oxygenta Pharmaceutical Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Oxygenta Pharmaceutical Ltd
Historical P/E Ratio of Oxygenta Pharmaceutical Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Oxygenta Pharmaceutical Ltd
Historical Revenue of Oxygenta Pharmaceutical Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Oxygenta Pharmaceutical Ltd
Historical EBITDA of Oxygenta Pharmaceutical Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Oxygenta Pharmaceutical Ltd
Historical Net Profit of Oxygenta Pharmaceutical Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Oxygenta Pharmaceutical Ltd
Dividend Payout Over Time
About Oxygenta Pharmaceutical Ltd
- Oxygenta Pharmaceutical Limited (Formerly known S S Organics Ltd) was incorporated as Private Limited Company in year 1990 and converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
- Later, the Company changed its name from S.S. Organics Ltd. to Oxygenta Pharmaceutical Limited in 2021-22. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.
- The Company is doing contract manufacturing work for APL and also having its own production.
- The Company is engaged in manufacture of bulk drugs.
- It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.
Oxygenta Pharmaceutical Ltd News Hub
Oxygenta Pharmaceutical reports standalone net loss of Rs 1.36 crore in the June 2024 quarter
Net Loss of Oxygenta Pharmaceutical reported to Rs 1.36 crore in the quarter ended June 2024 as agai
Read more
16 Aug 24
Oxygenta Pharmaceutical to discuss results
Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 August 20
Read more
12 Aug 24
Oxygenta Pharmaceutical schedules AGM
Oxygenta Pharmaceutical announced that the 31th Annual General Meeting (AGM) of the company will be
Read more
18 Sept 24
Oxygenta Pharmaceutical announces board meeting date
Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 November
Read more
11 Nov 24